<DOC>
	<DOCNO>NCT00959556</DOCNO>
	<brief_summary>RATIONALE : Studying gene express sample blood patient cancer may help doctor identify biomarkers related cancer . It may also help doctor predict patient respond chemotherapy . PURPOSE : This clinical trial study blood sample patient breast cancer .</brief_summary>
	<brief_title>Study Blood Samples Patients With Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Identify constitutional gene variant associate change response . OUTLINE : Blood sample collect periodically analysis genetic factor .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm breast carcinoma Received firstline chemotherapy ( neoadjuvant metastatic setting ) comprise anthracyclines and/or taxanes , include second primary cancer Patient agree conservative surgery Hormone receptor status specify PATIENT CHARACTERISTICS : Menopausal status specify No contraindication chemotherapy comprise anthracyclines and/or taxanes PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior adjuvant therapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IA breast cancer</keyword>
	<keyword>stage IB breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
</DOC>